Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DXC | Common Stock | Options Exercise | $870K | +50.2K | +30.25% | $17.33 | 216K | Feb 7, 2022 | Direct | F1 |
transaction | DXC | Common Stock | Sale | -$1.84M | -50.2K | -23.22% | $36.66 | 166K | Feb 7, 2022 | Direct | F1, F2 |
transaction | DXC | Common Stock | Sale | -$82.7K | -2.24K | -1.35% | $36.92 | 164K | Feb 7, 2022 | Direct | F1 |
transaction | DXC | Common Stock | Sale | -$51.5K | -1.4K | -0.85% | $36.93 | 162K | Feb 7, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DXC | Options (rights to buy) | Options Exercise | -$870K | -50.2K | -100% | $17.33 | 0 | Feb 7, 2022 | Common Stock | 50.2K | $17.33 | Direct | F3 |
Id | Content |
---|---|
F1 | Amount reported includes unvested Restricted Stock Units and vested, unreleased Career Shares. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.40 to $37.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | Pursuant to the anti-dilution provisions of the registrant's 2017 Omnibus Incentive Plan, the number of Options granted was adjusted in connection with the spin-off of the registrant's United States Public Sector business using a conversion ratio of 0.8649 from 43,414 Options to 50,195 Options. |